Heilsa Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2021.
2021 Delhi, Delhi, India Active
Last Updated:
Access Report
About Heilsa Life Sciences Private Limited

Heilsa Life Sciences Private Limited, a active private limited company, was established on 26 September 2021 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100DL2021PTC387167. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹24.00 Cr and a paid-up capital of ₹16.00 Cr.

It upholds a compliant status. Employing 1 professional, Its leadership includes Yasha Agarwal (Director), Ruchir Gupta (Managing Director), Sumit Kumar Agarwal (Director). Past directors included Ruchir Gupta, Manoj Agarwal, Vijaysing Krupalsing Bhandari. It holds ₹211.25 Cr open charges and ₹147.00 Cr settled loans. Its latest AGM occurred on 12 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No.404/65, Pragati Tower Rajendra Place, Delhi, Delhi, 110008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100DL2021PTC387167

  • Registration Number

    387167

  • Incorporation Date

    26 September 2021

  • Authorized Capital

    ₹24.00 Cr

  • Paid-Up Capital

    ₹16.00 Cr

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 24.00 Cr
  • Paid Up Capital ₹ 16.00 Cr
  • Company Age 4 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 211.25 Cr
  • Satisfied Charges ₹ 147.00 Cr
  • Revenue Growth **** %
  • Profit Growth **** 919.66%
  • Ebitda **** -100.23%
  • Net Worth 1410.85%
  • Total Assets **** 138.42%
Company report

Heilsa Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Heilsa Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Heilsa Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Yasha Agarwal Director 25 Jan 2023 Current
Ruchir Gupta Managing Director 26 Sep 2021 Current
Sumit Kumar Agarwal Director 26 Sep 2021 Current
Vijaysing Krupalsing Bhandari Director 16 Mar 2022 Current
Puneet Kansal Whole-Time Director 26 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Sep 2023 Past
Pramod Abcsdd Director 01 Jan 2023 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 31 Oct 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Heilsa Life Sciences.

Heilsa Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 919.66% increase in profit. The company's net worth Soared by an impressive increase of 1410.85%.

Heilsa Life Sciences revenue growth over time
Heilsa Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 138.42%
*******
*******
*******
*******
Profit or Loss
*******
 919.66%
*******
*******
*******
*******
Net Worth
*******
 1410.85%
*******
*******
*******
*******
EBITDA
*******
 -100.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Heilsa Life Sciences?

Unlock access to Heilsa Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,112,500,000.00

Satisfied Charges

₹1,470,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 211.25 Cr
Latest Charge Details
Date Lender Amount Status
13 Oct 2023 Others ₹147.00 Cr Open
11 Mar 2022 Others ₹64.25 Cr Open
11 Mar 2022 Others ₹147.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Heilsa Life Sciences?

Unlock and access historical data on people associated with Heilsa Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Heilsa Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heilsa Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Heilsa Life Sciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Heilsa Life Sciences Private Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Heilsa Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was documented.

  • Charges

    A charge with Others of Rs. 64.25 Cr registered on 11 Mar 2022 with Charge ID 100566475 was modified on 18 Dec 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 147.00 Cr registered on 13 Oct 2023 with Charge ID 100810798 was modified on 16 Dec 2024. was documented.

  • Charges

    Progress on A charge registered on 11 Mar 2022 via Charge ID 100566472 with Others was fully satisfied on 03 Nov 2023. was documented.

  • Charges

    A charge with Others amounted to Rs. 147.00 Cr with Charge ID 100810798 was registered on 13 Oct 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Heilsa Life Sciences Private Limited?

The CIN of Heilsa Life Sciences Private Limited is U24100DL2021PTC387167.

Where is Heilsa Life Sciences Private Limited headquartered?

Heilsa Life Sciences Private Limited is headquartered at Flat No.404/65, Pragati Tower Rajendra Place, Delhi, Delhi, 110008.

When was Heilsa Life Sciences Private Limited incorporated?

Heilsa Life Sciences Private Limited was incorporated on 26 September 2021.

Who are the current directors of Heilsa Life Sciences Private Limited?

The current directors of Heilsa Life Sciences Private Limited are

What is the primary industry of Heilsa Life Sciences Private Limited?

The primary industry of Heilsa Life Sciences Private Limited is Pharma.

Is Heilsa Life Sciences Private Limited a listed company?

Heilsa Life Sciences Private Limited is unlisted.

What is the capital structure of Heilsa Life Sciences Private Limited?

The authorized capital of Heilsa Life Sciences Private Limited is ₹24.00 Cr, and the paid-up capital is ₹16.00 Cr.

What is the compliance status of Heilsa Life Sciences Private Limited?

The compliance status of Heilsa Life Sciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available